The effect of ontogenetic development on the anticonvulsant activity of midazolam
Language English Country Netherlands Media print
Document type Journal Article
PubMed
1588800
DOI
10.1016/0024-3205(92)90421-k
PII: 0024-3205(92)90421-K
Knihovny.cz E-resources
- MeSH
- Anticonvulsants pharmacology MeSH
- Rats, Inbred Strains MeSH
- Injections, Intraperitoneal MeSH
- Rats MeSH
- Midazolam administration & dosage pharmacology MeSH
- Brain drug effects MeSH
- Pentylenetetrazole antagonists & inhibitors MeSH
- Growth physiology MeSH
- Dose-Response Relationship, Drug MeSH
- Seizures chemically induced prevention & control MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Anticonvulsants MeSH
- Midazolam MeSH
- Pentylenetetrazole MeSH
The anticonvulsant effects and duration of protective action of midazolam against Metrazol induced seizures were studied in 528 rats aged 7,12,18,25 and 90 days. The doses of 0.025, 0.05, 0.25, 0.5 and 1.0 mg/kg were administered immediately before Metrazol (100 mg/kg in all but 18-day-old animals where 90 mg/kg were given) for detection of antimetrazol activity at all age groups. The doses of 0.05, 0.25, and/or 0.5 mg/kg were used to study the time course of the protective action of midazolam. Each experimental group consisted of eight animals. Dose-dependent antimetrazol effects of midazolam till now described only in adult animals were demonstrated at all developmental stages studied. There were no qualitative differences in these effects among age groups studied. Midazolam action was better expressed against major Metrazol seizures than against minimal Metrazol seizures. Duration of the protective action depended on the dose tested at all developmental stages, as a rule, lasted longer in young animals than in adult rats. Only quantitative changes of action were found.
References provided by Crossref.org
Epilepsy Research in the Institute of Physiology of the Czech Academy of Sciences in Prague
Convulsant action of a benzodiazepine receptor agonist/inverse agonist Ro 19-4603 in developing rats